Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e8432ebff5a06ee8a6ffec8cc7611fbd |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2008-10-28^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_324c43121437f84376d56033defb1bf5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cba0b6ef718f413586bbbfc016cc77c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d629f311baca323ccbb684e42d483b91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab3c8312907f2be84689bb4fad794fed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2572f863fab7542c78b11d0cf87fa0b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65cc2844ef0da3957ae1729311bea84d |
publicationDate |
2012-02-24^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
NZ-585357-A |
titleOfInvention |
Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents |
abstract |
Disclosed are 4-(tetrazol-5-yl)-quinazoline derivatives represented by general formula (I). Processes for making the compounds are disclosed as well as the use of the compounds of formula (I) for treating cancer. |
priorityDate |
2007-10-29^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |